<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015979"><a href="http://purl.obolibrary.org/obo/MONDO_0015979">MONDO:0015979</a></h3>
<p><strong>Label:</strong> genetic susceptibility to infections due to particular pathogens</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0017897">MONDO:0017897</a> (autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0015279">MONDO:0015279</a> (chronic mucocutaneous candidiasis (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0017899">MONDO:0017899</a> (autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0017898">MONDO:0017898</a> (autosomal recessive mendelian susceptibility to mycobacterial diseases due to a partial deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0019146">MONDO:0019146</a> (mendelian susceptibility to mycobacterial diseases), <a href="http://purl.obolibrary.org/obo/MONDO_0012521">MONDO:0012521</a> (herpes simplex encephalitis), <a href="http://purl.obolibrary.org/obo/MONDO_0017905">MONDO:0017905</a> (X-linked mendelian susceptibility to mycobacterial diseases), <a href="http://purl.obolibrary.org/obo/MONDO_0008856">MONDO:0008856</a> (immunodeficiency 27A),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_319569">Orphanet:319569</a>, <a href="http://www.orpha.net/ORDO/Orphanet_319605">Orphanet:319605</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300645">OMIM:300645</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614850">OMIM:614850</a>, <a href="http://www.orpha.net/ORDO/Orphanet_1334">Orphanet:1334</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616532">OMIM:616532</a>, <a href="http://purl.obolibrary.org/obo/OMIM_209950">OMIM:209950</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613002">OMIM:613002</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610551">OMIM:610551</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613108">OMIM:613108</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615527">OMIM:615527</a>, <a href="http://www.orpha.net/ORDO/Orphanet_319543">Orphanet:319543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_1930">Orphanet:1930</a>, <a href="http://www.orpha.net/ORDO/Orphanet_319535">Orphanet:319535</a>, <a href="http://www.orpha.net/ORDO/Orphanet_319539">Orphanet:319539</a>, <a href="http://purl.obolibrary.org/obo/OMIM_607644">OMIM:607644</a>, <a href="http://purl.obolibrary.org/obo/OMIM_114580">OMIM:114580</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300636">OMIM:300636</a>, <a href="http://purl.obolibrary.org/obo/OMIM_247650">OMIM:247650</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614162">OMIM:614162</a>, <a href="http://purl.obolibrary.org/obo/OMIM_252250">OMIM:252250</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616445">OMIM:616445</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613953">OMIM:613953</a>, <a href="http://www.orpha.net/ORDO/Orphanet_748">Orphanet:748</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613956">OMIM:613956</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614849">OMIM:614849</a>, <a href="http://purl.obolibrary.org/obo/OMIM_212050">OMIM:212050</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99898">Orphanet:99898</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002718">HP:0002718</a> (Recurrent bacterial infections))) 56.60%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002718">HP:0002718</a> (Recurrent bacterial infections))) 56.60%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002718">HP:0002718</a> (Recurrent bacterial infections))) 56.60%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012823">HP:0012823</a> (Clinical modifier))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010974">HP:0010974</a> (Abnormality of myeloid leukocytes))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0007499">HP:0007499</a> (Recurrent staphylococcal infections))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0003674">HP:0003674</a> (Onset))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0003549">HP:0003549</a> (Abnormality of connective tissue))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002733">HP:0002733</a> (Abnormality of the lymph nodes))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002726">HP:0002726</a> (Recurrent Staphylococcus aureus infections))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002090">HP:0002090</a> (Pneumonia))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001911">HP:0001911</a> (Abnormality of granulocytes))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000976">HP:0000976</a> (Eczematoid dermatitis))) 54.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002841">HP:0002841</a> (Recurrent fungal infections) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system))) 54.33%</li>
</ul>
</body>
</html>
